Skip to main content

D. E. Shaw & Co., Inc.

Position in MYGN — Myriad Genetics Inc

CIK 1009207 New York, NY

Position in MYGN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$20,248,758
-$7,458,178 QoQ
Shares Held
4,499,724
-0.1% QoQ
Ownership
4.76%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

D. E. Shaw & Co., Inc. holds $1,656,514,763 across 27 Diagnostics & Research names. MYGN ranks #13 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MYGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $20,248,758 4,499,724
2025-12-31 $27,706,936 4,505,193
2025-09-30 $32,962,552 4,559,136
2025-06-30 $23,956,048 4,511,497
2025-03-31 $22,375,620 2,522,618
2024-12-31 $24,949,648 1,819,814
2024-09-30 $31,536,435 1,151,385
2024-06-30 $27,560,230 1,126,747
2024-03-31 $26,993,528 1,266,113
2023-12-31 $34,476,996 1,801,306
2023-09-30 $34,933,916 2,177,925
2023-06-30 $46,986,369 2,027,022
2023-03-31 $46,049,409 1,982,325
2022-12-31 $26,949,422 1,857,300
2022-09-30 $33,513,370 1,756,466
2022-06-30 $37,082,425 2,040,860
2022-03-31 $47,541,664 1,886,574
2021-12-31 $52,649,870 1,907,604
2021-09-30 $64,866,153 2,008,862
2021-06-30 $68,580,817 2,242,669
2021-03-31 $80,988,077 2,659,707
2020-12-31 $63,569,425 3,215,449
2020-09-30 $44,510,904 3,413,413
2020-06-30 $37,301,001 3,289,330
2020-03-31 $38,353,060 2,680,158